JPS61165326A - 過酸化脂質形成抑制剤、リソゾーム放出・活性酸素産生抑制剤及びヒスタミン遊離抑制剤 - Google Patents

過酸化脂質形成抑制剤、リソゾーム放出・活性酸素産生抑制剤及びヒスタミン遊離抑制剤

Info

Publication number
JPS61165326A
JPS61165326A JP61006118A JP611886A JPS61165326A JP S61165326 A JPS61165326 A JP S61165326A JP 61006118 A JP61006118 A JP 61006118A JP 611886 A JP611886 A JP 611886A JP S61165326 A JPS61165326 A JP S61165326A
Authority
JP
Japan
Prior art keywords
agent
suppressing
lipid peroxide
histamine
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61006118A
Other languages
English (en)
Japanese (ja)
Inventor
Kohei Umetsu
梅津　浩平
Satoshi Yuasa
聡 湯浅
Yoshimi Morita
良美 森田
Seiro Taniguchi
谷口　誠朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Industries Ltd filed Critical Mitsubishi Chemical Industries Ltd
Publication of JPS61165326A publication Critical patent/JPS61165326A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP61006118A 1985-01-17 1986-01-14 過酸化脂質形成抑制剤、リソゾーム放出・活性酸素産生抑制剤及びヒスタミン遊離抑制剤 Pending JPS61165326A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69230985A 1985-01-17 1985-01-17
US692309 2000-10-20

Publications (1)

Publication Number Publication Date
JPS61165326A true JPS61165326A (ja) 1986-07-26

Family

ID=24780061

Family Applications (2)

Application Number Title Priority Date Filing Date
JP61006118A Pending JPS61165326A (ja) 1985-01-17 1986-01-14 過酸化脂質形成抑制剤、リソゾーム放出・活性酸素産生抑制剤及びヒスタミン遊離抑制剤
JP61006117A Pending JPS61165327A (ja) 1985-01-17 1986-01-14 肝疾患治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61006117A Pending JPS61165327A (ja) 1985-01-17 1986-01-14 肝疾患治療薬

Country Status (6)

Country Link
EP (1) EP0201359A3 (enExample)
JP (2) JPS61165326A (enExample)
BE (1) BE904059A (enExample)
CH (2) CH670642A5 (enExample)
FR (1) FR2578164B1 (enExample)
IT (1) IT1213024B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
US20050049278A1 (en) * 2003-08-27 2005-03-03 Youssef Bennani Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
CN101735229A (zh) * 2009-12-24 2010-06-16 沈阳药科大学 四氢异喹啉类化合物及其制备方法和用途
FR3111071B1 (fr) * 2020-06-04 2023-01-13 H4 Orphan Pharma Utilisation de ligands multifonctionnels pour traiter les syndromes de détresse respiratoire et le choc cytokinique liés aux infections virales à coronavirus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1206909B (de) * 1959-08-14 1965-12-16 Maurice Jeanson Verfahren zur Herstellung von Inhibitoren der Histidindecarboxylase
FR2424271A1 (fr) * 1978-04-28 1979-11-23 Laire Chimie Sa De Derives de phtalidyl-isoquinoleines, leur preparation et leur application comme medicaments
DE2964836D1 (en) * 1979-10-22 1983-03-24 Calaire Chimie Sa Phthalide-isoquinoline derivatives, their preparation and their use in medicaments

Also Published As

Publication number Publication date
IT1213024B (it) 1989-12-07
IT8619100A0 (it) 1986-01-17
EP0201359A2 (en) 1986-11-12
FR2578164A1 (fr) 1986-09-05
CH670642A5 (enExample) 1989-06-30
EP0201359A3 (en) 1989-07-19
JPS61165327A (ja) 1986-07-26
FR2578164B1 (fr) 1990-08-10
BE904059A (fr) 1986-07-17
CH677731A5 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
AU776053B2 (en) Diazepan derivatives or salts thereof
US4483867A (en) Antifibrinolytically active derivatives of tranexamic acid
JPS607997B2 (ja) ヒダントイン誘導体治療剤
JPS6028979A (ja) イミダゾキナゾリン類化合物
JPS6277375A (ja) Ｎ―置換２―アミノチアゾール類及び治療用組成物
JPS63264421A (ja) 高脂質血症治療剤
JPH0717589B2 (ja) 新規１，３―ジカルボニル化合物およびその組成物
US4778792A (en) Use of 7-acyl benzoxazinones and their derivatives in treating atheromatous disorders
CA1047501A (fr) Derives hydroxyles ou carboxyles du benzimidazole et leur procede de preparation
US4818760A (en) Derivatives of pyridylsulfinyl(benz-or thieno-)imidazoles and their use as gastric secretion inhibiting substances
JPH01294670A (ja) ２−（ピペラジニル）−２−オキソエチレン−置換フラボノイド誘導体、その製法およびそれを含有する医薬組成物
JPH06321944A (ja) ピリドピリミジンジオン類、その製造方法および薬剤としてのその使用
US5753667A (en) 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
US5304548A (en) Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
JPS62135423A (ja) 低酸素症改善剤
FI91871B (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
JP4717305B2 (ja) ベンズイミダゾール化合物及びこれを含む医薬
WO1996005202A1 (en) Imidazoquinoline derivative
JPS59225187A (ja) テトラヒドロ−β−カルボリン誘導体及びその製法
CH670642A5 (enExample)
JPWO2001000588A1 (ja) ベンズイミダゾール化合物及びこれを含む医薬
JPS6163682A (ja) 新規テトラヒドロ‐β‐カルボリン誘導体及びその製法
JPS6193118A (ja) 肝障害治療・予防剤
JPH02289557A (ja) 新規な５―アシルベンゾキサゾリノン誘導体
CN118440084A (zh) 脱氧鸭嘴花酮碱衍生物及其制备方法和在药物中的应用